MedicineOncologyRadiation OncologyDna RepairMolecular OncologyRadiobiologyBiological Effects Of RadiationBreast Cancer RadiobiologyCellular Radiation ResponseRadiation BiologyRadiation SensitivityRadiation TherapyCancer Cell RadiosensitivityCellular RadiosensitivityClonogenic Survival AssaysDna Double-strand BreaksParp InhibitionPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase 1γ-H2ax Foci Formation
OBJECTIVE: To study the function and mechanism of combined PARP-1 and BRCA genes in regulating the radiosensitivity of breast cancer cells by poly ADP-ribose polymerase-1 (PARP-1) inhibitor 3-amion benzamide (3-AB) onBRCA mutant and non-mutant breast cancer cells. METHODS: Four groups of BRCA mutant cells MDA-MB-436 and BRCA non-mutant cells MDA-MB-231 were divided respectively into control (CTRL), ionizing radiation alone (IR), 3-AB alone (3-AB), and ionizing radiation combined with 3-AB (IR+3-AB) groups. The γ-H2AX foci were detected by immunofluorescence assay to show the DNA double-strand damage. The clonogenic cell survival assay was applied to evaluate the radiosensitivity of breast cancer cells, and flow cytometry was used to assess the percentage of apoptosis cells. RESULTS: < 0.05). CONCLUSIONS: Compared with non-BRCA mutant MDA-MB-231 cells, the BRCA mutant breast cancer MDA-MB-436 cells could incur significantly greater DNA damage, and therefore the radiosensetivity of MDA-MB-436 cells is higher than that of MDA-MB-231 cells. The inhibitor of PARP-1, which can block the repair of single-strand damage caused by radiation, can further enhance the level of apoptosis and radiosensitivity of BRCA-mutant cells.
9
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations
PARP inhibitors stumble in breast cancer
Malini Guha · Nature Biotechnology · 2011 · 111 citations
Medicine, Cancer Biology, Oncology +14
Head and neck cancer radiosensitization by the novel poly(ADP‐ribose) polymerase inhibitor GPI‐15427
Khurram Khan, Koji Araki, Daiyou Wang et al. · Head & Neck · 2009 · 77 citations
Medicine, Oncology, Pharmacology +15